Identity
- Trade Name
- HEPRO.US MM1000 BRAND CT40 GLUCOSEMETER KIT - FDA UDI
- Generic Name
- Glucose/haematocrit monitoring system IVD, home-use FDA UDI
- Device Name
- Case/Carton of 40 boxes of ONE GLUCOSEMETER KIT HEPRO.US MM1000 Copy FDA UDI
- Model / Reference
- CT Glucosemeter kits FDA UDI
- Description
- Case/Carton of 40 boxes of ONE GLUCOSEMETER KIT HEPRO.US MM1000 Copy FDA UDI
Identifiers
- Primary DI / UDI-DI
- 00850578007396 FDA UDI
- FDA Product Code
- NBW FDA UDIJJX FDA UDICGA FDA UDI
- GMDN Term
- Glucose/haematocrit monitoring system IVD, home-use FDA UDI
Classification
- Device Class
- Class II FDA UDI
- Regulation Number
- 862.1345 FDA UDI862.1660 FDA UDI
- Commercial Distribution
- In Commercial Distribution FDA UDI
Clinical & Handling
Sterile
Yes
FDA UDI
Single Use
Yes
FDA UDI
Implantable
No
FDA UDI
Contains Latex
No
FDA UDI
Prescription Use
No
FDA UDI
Over-the-Counter
No
FDA UDI
Convenience Kit
No
FDA UDI
Combination Product
No
FDA UDI
HCT/P
No
FDA UDI
Premarket Exempt
Yes
FDA UDI
Lot / Batch Number
Yes
FDA UDI
Serial Number
Yes
FDA UDI
Expiration Date
Yes
FDA UDI
Manufacturing Date
Yes
FDA UDI
MR Safe FDA UDI
Category: Glucose/haematocrit monitoring system IVD, home-use
Hepro.us Mm1000 Brand Ct40 Glucosemeter Kit - by Hepro.us Inc. — Class II — FDA UDI — listed in FDA GUDID — regulatory data on deviCERTS
Similar devices
Also classified as Glucose/haematocrit monitoring system IVD, home-use.
- HEPRO.US MM1000 Blood Glucose Monitoring System Kit — HEPRO.US INC. · Class I
- GLUCOSE TEST STRIP 50 CT. — HEPRO.US INC. · Class II
Authorization Coverage (1 country)
Regulatory Authorizations
United States Pending data
FDA UDI
| Source | Region | Type | Cert / Approval No. | Class | Status |
|---|---|---|---|---|---|
| FDA UDI | United States | FDA UDI | Registered in GUDID | Class II | Pending data |
Is this your device? Claim it to add documentation and request validation.
Manufacturer
- Manufacturer
- Hepro.us Inc.
Sources (1)
- FDA UDI 9d71713c-0f26-4c56-960b-c685a5cc2917 33 fields · synced Jun 8, 2026